This company listing is no longer active
Salud financiera de hoja de balance de AVEO Pharmaceuticals
Salud financiera controles de criterios 6/6
Información clave
134.1%
Ratio deuda-patrimonio
US$38.68m
Deuda
| Ratio de cobertura de intereses | n/a |
| Efectivo | US$77.40m |
| Patrimonio | US$28.85m |
| Total pasivo | US$72.39m |
| Activos totales | US$101.23m |
Actualizaciones recientes sobre salud financiera
No hay actualizaciones
Recent updates
Análisis de la situación financiera
Pasivos a corto plazo: VPA1's short term assets ($100.7M) exceed its short term liabilities ($42.4M).
Pasivo a largo plazo: VPA1's short term assets ($100.7M) exceed its long term liabilities ($30.0M).
Historial y análisis de deuda-patrimonio
Nivel de deuda: VPA1 has more cash than its total debt.
Reducción de la deuda: VPA1 had negative shareholder equity 5 years ago, but is now positive and has therefore improved.
Hoja de balance
Análisis de cash runway
En el caso de las empresas que de media han sido deficitarias en el pasado, evaluamos si tienen al menos 1 año de cash runway.
Cash runway estable: VPA1 has sufficient cash runway for more than 3 years based on its current free cash flow.
Pronóstico de cash runway: VPA1 has sufficient cash runway for 2.9 years if free cash flow continues to reduce at historical rates of 12.7% each year.